Related Experiment Video

Updated: Apr 9, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus

Michael C Brown1, Matthias Gromeier1

  • 1Department of Molecular Genetics & Microbiology, Duke University Medical Center, Box 3020, Research Drive, Durham, NC 27710, USA; Department of Neurosurgery, Duke University Medical Center, Box 3020, Research Drive, Durham, NC 27710, USA.

Current Opinion in Virology
|June 18, 2015
PubMed

Insights

Polio/rhinovirus recombinant PVSRIPO shows promise for treating glioblastoma by selectively killing cancer cells and triggering immune responses. This oncolytic virus therapy leverages both direct cytotoxicity and immunogenicity for anti-tumor effects.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Oncolytic viruses (OVs) are emerging as a promising cancer therapy.
  • Poliovirus (PV)-based recombinant PVSRIPO demonstrates potential in clinical trials for recurrent glioblastoma (GBM).
  • PVSRIPO's efficacy relies on selective cancer cell killing and inducing an immune response.

Purpose of the Study:

  • To investigate the mechanisms underlying PVSRIPO's cancer cell cytotoxicity.
  • To understand how PVSRIPO's immunogenicity contributes to tumor regression.
  • To explore the synergistic relationship between PVSRIPO's cytotoxicity and immunogenicity in anti-cancer responses.

Main Methods:

  • Delineating the molecular mechanisms of PVSRIPO-mediated cancer cell death.
  • Analyzing the host immune responses triggered by PVSRIPO infection in tumors.
  • Evaluating the combined effects of cytotoxicity and immunogenicity on anti-neoplastic activity.

Main Results:

  • PVSRIPO exhibits selective cytotoxicity against cancer cells.
  • PVSRIPO infection elicits an in situ immunogenic imprint, stimulating anti-tumor immunity.
  • Cytotoxicity and immunogenicity act in a complementary manner to enhance anti-tumor efficacy.

Conclusions:

  • PVSRIPO's anti-cancer effect is a result of both direct tumor cell killing and immune system activation.
  • Understanding these mechanisms is crucial for optimizing PVSRIPO as an immunotherapeutic agent for glioblastoma.
  • Further research into PVSRIPO's dual action holds potential for advancing cancer treatment strategies.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

5.9K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.6K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
33
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
53